LAMDARCT trial capsules for the Belfast Trust come from Almac
- Belfast Health and Social Care Trust
- Northern Ireland
- Direct
- 19 January 2026 to 5 January 2030
Belfast Health and Social Care Trust has hired Almac Group to make and test over-encapsulated tablets and matching placebo capsules for the LAMDARCT clinical trial. The work covers both production and quality control testing, so the trial's supplies meet research standards.
The trust awarded the £494,448 contract directly in December 2025. It runs for four years, to January 2030.
Contract ends January 2030
- What
- Aseptic compounding, specials and contract pharmaceutical manufacturing
- Supplier
- Almac Group
- Value
- £494,448
- How it was bought
- Direct
- Dates and next
- Jan 2026 to Jan 2030